Curt Bradshaw Arrowhead Pharmaceuticals, Inc. (ARWR) insider trading activity

ARWR Quotes by TradingView

Curt Bradshaw is Chief Scientific Officer of ARROWHEAD PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of ARWR, which is worth approximately $0. The most recent transaction as insider was on Nov 20, 2020, when has been sold 15,625 shares (Common Stock) at a price of $68.73 per share, resulting in proceeds of $1,073,906. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Curt Bradshaw Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 20 2020
SELL
Open market or private sale
$1,073,906 $68.73 p/Share
15,625 Reduced 100.0%
0 Common Stock
Nov 19 2020
SELL
Open market or private sale
$1,084,219 $69.39 p/Share
15,625 Reduced 50.0%
15,625 Common Stock

Also insider at

NBSE
NeuBase Therapeutics, Inc. Healthcare
Chief Scientific Officer
CB

Curt Bradshaw

Chief Scientific Officer
Pasadena, CA

Track Institutional and Insider Activities on ARWR

Follow ARROWHEAD PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARWR shares.

Notify only if

Insider Trading

Get notified when an Arrowhead Pharmaceuticals, Inc. insider buys or sells ARWR shares.

Notify only if

News

Receive news related to ARROWHEAD PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ARWR